Piper Sandler Reiterates Overweight on Glaukos, Raises Price Target to $195

Benzinga Newsdesk www.benzinga.com Positive 80.9%

Neg 0% Neu 0% Pos 80.9%

Piper Sandler analyst Adam Maeder reiterates Glaukos (NYSE:GKOS) with a Overweight and raises the price target from $165 to $195.